期刊文献+

NO抑制体外IFN-γ刺激成肌细胞/肌管NLRP3炎性小体活化 被引量:1

Inhibition of nitric oxide on activation of NLRP3 inflammasome of myoblast/myotubes stimulated by IFN-γ in vitro
下载PDF
导出
摘要 目的观察一氧化氮供体硝普钠(SNP)、一氧化氮合酶抑制剂(L-NAME)对体外炎性培养(IFN-γ刺激)成肌细胞/肌管NLRP3炎症小体活化的影响。方法利用IFN-γ刺激小鼠C2C12成肌细胞/肌管,q PCR和Western blot分析炎性小体(ASC、NLRP3、caspase-1)的形成及活化、ELISA检测细胞培养上清IL-1β的分泌。进一步利用L-NAME和SNP处理IFN-γ诱导的C2C12细胞/肌管,分析炎性小体的形成、活化及IL-1β的分泌。结果 IFN-γ刺激培养后,成肌细胞/肌管中NLRP3、ASC和mature-caspase-1表达水平上调(P<0.01)。较之未刺激的细胞,IFN-γ诱导会显著上调成肌细胞/肌管培养基中的IL-1β浓度(P<0.01)。SNP处理后6 h,分化肌管(IFN-γ刺激48 h)内炎性小体(ASC、NLRP3、caspase-1)mRNA和蛋白水平较单纯刺激细胞显著下调(P<0.01),L-NAME则上调ASC、NLRP3、caspase-1表达水平(P<0.05)。与上述结果一致,SNP和L-NAME处理同时分别下调或上调培养基中IL-1β浓度(P<0.05)。结论在炎性条件下,成肌细胞/肌管具备合成并活化NLRP3炎性小体的能力。NO对炎性小体的形成及活化有一定的抑制作用。 Objective To observe the effect of sodium nitroprusside (SNP) or nitro L arginine acid methyl ester (L-NAME) on the NLRP3 inflammasome activation of C2C12 myoblast or differentiated myotubes in inflammatory culture in vitro. Methods C2C12 myoblasts were stimulated by IFN-γ, then the formation and activation of NLRP3 inflammasome were analyzed by qPCR and Western blot, and the secretion of IL- 1β in the cell culture supernatant was detected by ELISA. Further, C2C12 myoblasts induced by IFN-γwere treated by L-NAME or SNP respectively, then the formation and activation of NLRP3 inflammasome and the secretion of IL-1 [3 were analyzed. Results qPCR andWestern blot detection confirmed that expression of NLRP3, ASC and mature-caspase-I in C2C12 myoblasts or differ- entiation myotubes induced by IFN-γwas up-regulated(P 〈0. 01 ). The IL-1β concentration in the medium of C2C12 induced by IFN-γwas up-regulated as compared with that of the non stimulating cells(P 〈0. 01 ). At 6 h after SNP treatment, a significant down-regulation of mRNA and protein levels of differentiation myotube inflammasome (ASC and NLRP3, caspase-1 ) was found (P 〈 0. 01 ) and a contrary result was obtained after L-NAME treatment (P 〈 0. 05 ). Consistent with the above results, the expression of IL- 115 in the culture supernantent was down-regulated or up-regulated by SNP or L-NAME respectively (P 〈 0. 05). Conclusions In inflammatory conditions, C2C12 myo- blasts or differentiation myotubes possess the ability to synthesize inflammasome NLRP3. NO may inhibit the NLRP3 inflammasome formation and activation.
出处 《基础医学与临床》 CSCD 2016年第3期331-336,共6页 Basic and Clinical Medicine
基金 国家自然科学基金(81171724 81371924) 广东省科技计划(2012B031800146) 广东省自然科学基金(2014A030313276)
关键词 NO C2C12细胞 炎性小体 nitric oxide C2C12 myoblast inflammasomes
  • 相关文献

参考文献1

二级参考文献50

  • 1Schroder K, Tschopp J. The inflammasomes. Cell 2010; 140:821-832.
  • 2Mariathasan S, Newton K, Monack DM, et al. Differential activation of the inflammasome by caspase-I adaptors ASC and Ipaf. Nature 2004; 430:213-218.
  • 3Allen IC, Scull MA, Moore CB, et al. The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. Immunity 2009; 30:556- 565.
  • 4Gross 0, Poeck H, Bscheider M, et al. Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence. Nature 2009; 459:433-436.
  • 5Eisenbarth SC, Colegio OR, O'Connor W, Sutterwala FS, Flavell RA. Crucial role for the Na1p3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature 2008; 453:1122-1126.
  • 6Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J. Goutassociated uric acid crystals activate the NALP3 inflammasome. Nature 2006; 440:237-241.
  • 7Dostert C, Petrilli V, Van 8ruggen R, Steele C, Mossman BT, Tschopp J. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 2008; 320:674- 677.
  • 8Duewell P, Kono H, Rayner KJ, et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 2010; 464:1357-1361.
  • 9Ichinohe T, Lee HK, Ogura Y, Flavell R, Iwasaki A. Inflammasome recognition of influenza virus is essential for adaptive immune responses. J Exp Med 2009; 206:79-87.
  • 10Kastner DL, Aksentijevich I, Goldbach-Mansky R. Autoinf1ammatory disease reloaded: a clinical perspective. Cell 2010; 140:784-790.

共引文献58

同被引文献3

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部